oral glp 1 agonist weight loss Medscape - The once-daily GLP-1 RA orforglipron produces clinically and statistically significant and cardiometabolic improvements, with safety comparable to that of injectable agents. http://ms.spr.ly/6180sozg6 GLP-1 agonists for weight loss:
Description
One patch
In terms of eating and dietary changes, 47% of GLP-1 users in PwCs survey reported eating smaller portions, and 56% said they now make healthier food choices
Frequency unknown: Angioedema, back pain, cutaneous vasculitis, interstitial lung disease, joint disorders, myalgia, pancreatitis, renal impairment, StevensJohnson syndrome, hepatic function abnormalities
Nagendra, L
So far, in the long run, obesity prevention and treatment strategies-whether at the individual or group level, have not been very successful (8)
